ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Infection"

  • 2020 American Transplant Congress

    Letermovir Treatment for Established Cytomegalovirus Infection in Transplant Recipients

    K. Linder1, C. Kovacs2, K. Mullane3, C. Wolfe4, N. Clark5, C. Butkus Small6, R. La Hoz7, J. Smith8, C. Kotton9, A. Limaye10, M. Malinis11, M. Hakki12, A. Mishkin13, A. Gonzalez14, D. Kaul1

    1U Michigan, Ann Arbor, MI, 2Cleveland Clinic, Cleveland, OH, 3U Chicago, Chicago, IL, 4Duke, Durham, NC, 5Loyola, Chicago, IL, 6Cornell, NYC, NY, 7UTSW, Dallas, TX, 8U Wisconsin, Madison, WI, 9Mass General, Boston, MA, 10U Washington, Seattle, WA, 11Yale, New Haven, CT, 12OHSU, Portland, OR, 13Temple, Philadelphia, PA, 14West Coast ID, Safety Harbor, FL

    *Purpose: The purpose of the study was to describe the patterns of use and clinical/virologic outcomes of letermovir treatment for established CMV infection in transplant…
  • 2020 American Transplant Congress

    Utilization of Hepatitis C Viremic Donors in Liver Transplantation. A Single Center Experience

    R. Cohen, N. Chandolias*, K. Khanmoradi, S. Campos, H. Kaul, J. Walter, S. Rossi, V. Navarro, R. Zaki

    Department of Digestive Disease and Transplantation, Albert Einstein Medical Center, Philadelphia, PA

    *Purpose: The evolution of effective direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV), in the setting of the well recognized organ shortage and the…
  • 2020 American Transplant Congress

    Hyperammonemia Syndrome in a Kidney Transplant Recipient Caused by Quinolone-Resistant Ureaplasma Infection

    A. B. Higgins1, R. Rogers2, A. J. Osband3, R. Gohh4, P. Morrissey3, A. Seo1, B. Chen1, D. Crabb5, S. Leal5, K. Waites5, D. Farmakiotis2, G. J. Nau2

    1Department of Medicine, Alpert Medical School of Brown University, Providence, RI, 2Division of Infectious Diseases, Alpert Medical School of Brown University, Providence, RI, 3Department of Surgery, Alpert Medical School of Brown University, Providence, RI, 4Division of Nephrology, Alpert Medical School of Brown University, Providence, RI, 5Division of Laboratory Medicine, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL

    *Purpose: Urease-producing bacteria release significant amounts of ammonia. Donor-derived Ureaplasma infections in lung transplant recipients have been implicated in the pathogenesis of hyperammonemia syndrome (HS).…
  • 2020 American Transplant Congress

    Correlation of CMV and EBV DNAemia in the Development of Invasive Fungal Disease among Pediatric Intestinal and Liver Transplant Recipients

    B. M. Chatani1, J. Garcia2, T. Beduschi3, A. Tekin3, R. Vianna3, I. A. Gonzalez1

    1Pediatric Infectious Disease, University of Miami Miller School of Medicine, Miami, FL, 2Pediatric Gastroenterology, University of Miami Miller School of Medicine, Miami, FL, 3Miami Transplant Institute, Miami, FL

    *Purpose: Invasive fungal disease (IFD) among pediatric solid organ transplant recipients is a relatively rare event, however often results in death. There are many factors…
  • 2020 American Transplant Congress

    BK Viremia: A Double Edged Sword – The Impact of Immunosuppression Reduction on Allograft Rejection

    A. Szczepanik1, A. Bixby1, C. Burrelli1, A. Padiyar2, T. Srinivas2, K. Chavin3

    1Pharmacy, University Cleveland Medical Center, Cleveland, OH, 2Nephrology, University Cleveland Medical Center, Cleveland, OH, 3Surgery, University Cleveland Medical Center, Cleveland, OH

    *Purpose: BK viremia (BKV) increases the risk of renal allograft loss following transplant. Guidelines recommend reduction of immunosuppression (IS) after BKV diagnosis, however, the ideal…
  • 2020 American Transplant Congress

    Ehrlichiosis Infection Presenting as Thrombotic Microangiopathy Early after Kidney Transplantation

    W. Hassan1, M. Talwar2, V. Balaraman2, B. Wall1, M. Molnar1

    1Medicine-Nephrology, University of Tennessee Health Science Center, Memphis, TN, 2Department of Surgery, Transplant Surgery, Methodist University Hospital, James D Eason Transplant Institute, Memphis, TN

    *Purpose: Fever of unknown origin and clinical picture of Thrombotic MicroAngiopathy (TMA) are diagnostic challenges in the early period after kidney transplantation. Here we present…
  • 2020 American Transplant Congress

    Peritoneal Dialysis in Delayed Graft Function, a Safe and Effective Option

    A. Gardezi, B. Muth, F. Aziz, N. Garg, M. Mohamed, A. Djamali, D. Mandelbrot, S. Parajuli

    University of Wisconsin, Madison, WI

    *Purpose: Peritoneal dialysis (PD) has been utilized increasingly in the past decade. Many of these patients undergo transplantation and may require dialysis for delayed graft…
  • 2020 American Transplant Congress

    Infectious Complications in Elderly Kidney Transplant Recipients Undergoing Desensitization

    S. Sethi, R. Najjar, A. Peng, A. Vo, S. Jordan, E. Huang

    Cedars Sinai Medical Center, West Hollywood, CA

    *Purpose: Data is limited on the impact of desensitization on infectious complications in elderly kidney transplant (KT) recipients. We examined infectious complications in elderly KT…
  • 2020 American Transplant Congress

    Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides Difficile Infection among Transplant Recipients

    V. Bajrovic1, T. Johnson2, A. Howard2, L. Allen3, G. Barber2, K. Schwarz2, M. Huang3, M. Abidi1, E. Benamu3, P. Ramanan3, M. Miller4

    1Division of Infectious Diseases, University of Colorado, Denver, CO, 2Department of Pharmacy, University of Colorado, Aurora, CO, 3Division of Infectious Diseases, University of Colorado, Aurora, CO, 4Department of Pharmacy, University of Colorado, Denver, CO

    *Purpose: Clostridioides difficile is an urgent health threat associated with significant morbidity and mortality. Recipients of solid organ (SOT) and hematopoietic-cell transplantations (HCT) are at…
  • 2020 American Transplant Congress

    Absence of Adverse Infectious Disease Outcomes in the Long-Term Follow-Up of Recipients of PHS Increased Risk Donor Organs: An Essential Tracking Program

    L. Irwin, J. Fishman

    Transplant Surgery, Massachusetts General Hospital, Boston, MA

    *Purpose: 37-41% of deceased donors in Region I are considered “PHS increased risk for infectious disease transmission” (IR) individuals, our Center developed guidelines for the…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 84
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences